Robert M. Anderson, EdD, of the University of Michigan, has spent his career spreading a message that patients respond best when education programs address what they want, not what an expert thinks they need.
As a child, Robert M. Anderson, EdD, hated school.
He hated the uniforms. The lectures. The domineering nuns of his parish school in Boston, in an Irish enclave with a 10:1 “pub to church” ratio.
He hated algebra, but was told to “pay attention because it’s important.”
“I’m 70, and it still isn’t important,” Anderson said.
Getting to the heart of what’s important—and discarding what’s not—has been the theme of Anderson’s career, one spent upending conventional wisdom on how the “experts” should teach persons with diabetes to managed their disease. It’s a message that’s as timely as ever, with CDC publishing data on obesity that some see as a “tipping point” and CMS finally moving this spring to pay for diabetes prevention in Medicare.
In a session with plenty of music (and no math), Anderson shared his journey in a session titled, “How My Hatred of School Led to a Passionate Commitment to Patient Empowerment.” Anderson had been scheduled to give the talk at the 2015 Scientific Sessions of the American Diabetes Association (ADA) as last year’s winner of the Richard R. Rubin Award, but he was unable to due to illness.
Friday’s lecture at the 76th Scientific Sessions in New Orleans began with the best-known music and scenes from the film, “Pink Floyd: The Wall,” with a column of expressionless schoolchildren forming a line into the meat grinder, while a professor screams nearby. Anderson used this to set the tone of what education felt like to him as a child.
“School was ‘Dead World,’ where curiosity came to die,” he said. Changing into his street clothes every afternoon was a glorious transition, “from the ‘Dead World’ into the ‘Living World.’ ”
He initially declined to attend college, but changed his mind to avoid going to Vietnam, because he opposed the war. There, he discovered psychology, philosophy, and sociology, and got a degree in the latter. Through an interest in counseling high school students, he took classes in “experiential learning,” which was nothing like he had experienced in his own primary education.
“We talked about it if it became a problem,” he said. “The Dead World could be brought back to life.”
When he got his EdD, Anderson got a job in Maine with the CDC, and was given the task of improving the quality of diabetes education. So he took a diabetes education class.
The first day, he thought, “Oh my God, I have been here before.” Dead World was back.
The complex scientific information was overwhelming, with an off-putting message, “You will comply!”
He ended up at the University of Michigan, where today he is professor emeritus of Learning Health Sciences and associate director of the Intervention and Technology Research Core of the Michigan Diabetes Research and Training Center.
There, Anderson formed a key professional partnership with Martha M. Funnell, MS, RN, CDE, FAADE, and together they designed a whole new way to teach people with diabetes to managed their disease. It started with a simple principle: their role was to empower people.
“There were no lectures,” Anderson said. He and Funnell discovered a simple fact: “People don’t care about diabetes. They care about their diabetes.”
Instead of asking patients to learn difficult scientific information that they’d never use, they focused on helping them learn to make good decisions. They saw immediate results, but patients hit a familiar wall after about 2 months. So, they developed support programs, all evidence-based.
He published seminal papers starting in 1985 with, “Is the problem of noncompliance all in our heads?”1 and several provocative papers addressing issues of race in diabetes education, including, “Into the heart of darkness: reflections on racism and diabetes care,”2 evoking the famous work by Joseph Conrad.
His methods start with the idea that empowering patients requires listening to them first, to understand their goals, limits, and concerns. This is especially true in the support phase after an initial intervention.
“It must be based on what patients want and need to know, instead of what we think they need to know,” Anderson said. “It reawakens their desire to control their diabetes better.”
In a nod to the host city, he concluded his tale of “the boy who hated school but devoted his life to education,” with music from Louis Armstrong: What a Wonderful World.
References
1. Anderson RM. Is the problem with noncompliance all in our heads? The Diabetes Educator. 1985;11(1)31-34.
2. Anderson RM. Into the heart of darkness: reflections on racism and diabetes care. The Diabetes Educator. 1998;24(6):689-692.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More